According to our latest research, the global Neurological Biomarker market size reached USD 8.9 billion in 2024, demonstrating robust growth driven by the rising prevalence of neurodegenerative diseases and advances in biomarker discovery technologies. The market is expected to grow at a CAGR of 12.4% from 2025 to 2033, projecting a market value of approximately USD 25.4 billion by 2033.
https://growthmarketreports.co....m/report/neurologica